Jacques Guyette is a highly accomplished biopharma analyst who brings exceptional skills and experience in competitive analysis, scientific exploration, diligence, strategic product planning, market research, and financial modeling across various therapeutic areas. He studied biological sciences at the University of Notre Dame, biochemistry at Carnegie Mellon University. He also completed his postdoctoral research fellow in regenerative medicine at Harvard Medical School and earned his Ph.D. and M.E. in biomedical engineering at Worcester Polytechnic Institute. Jacques has an impressive professional background in Competitive Intelligence & Analytics at Alexion Pharmaceuticals, where he honed his research and analysis skills to evaluate key opportunities in the market. He also previously worked in Cowen and Company as a Pharmaceutical Equity Research Analyst, where he covered Therapeutic areas including Oncology, Gastrointestinal, and Infectious Diseases. Jacques taught in Harvard Medical School, where he imparted his knowledge to aspiring health practitioners. He was also a Flagship VentureLabs Fellow, where he had hands-on experience in translational medicine and worked on a range of diagnostic and therapeutic platforms. Jacques also worked as a Research Fellow at both Harvard Medical School and Massachusetts General Hospital. In his role at Beacon VP Capital, where he served as Biotechnology Fund Research and Strategy, Jacques conducted extensive research and strategic analysis across the biopharmaceutical industry.